# Alterations in *PTEN* and *ESR1* promote clinical resistance to alpelisib plus aromatase inhibitors
## Razavi *et al.*
### https://www.nature.com/articles/s43018-020-0047-1
&nbsp;
&nbsp;
&nbsp;

![Front page](https://github.com/ndbrown6/MSK-BYL-NC/blob/master/ext/Alpelisib_AI.png)
